Comparison of efficacy between long-pulsed Nd:YAG laser and pulsed dye laser to treat rosacea-associated nasal telangiectasia

Kwon, Won Joo; Park, Bok Won; Cho, Eun Byul; Park, Eun Joo; Kim, Kwang Ho; Kim, Kwang Joong

doi:10.1080/14764172.2017.1418510

Cited by 18 publications

(20 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Kwon et al compared two different lasers, pulsed dye laser (PDL) and Nd:YAG(LPNY), and concluded that PDL is more safe and effective in the treatment of erythema and mild telangiectasia, while LPNY is better on thicker dilated vessels 5 …”

Section: Discussionmentioning

confidence: 99%

“…The laser devices that have been used the most for nasal telangiectasia are CO2 laser, potassium titanyl phosphate (KTP) laser, long‐pulsed neodymium:yttrium‐aluminum‐garnet Nd:YAG(LPNY) laser, erbium:yttrium‐aluminum‐garnet laser, and intense pulsed light (IPL) 2,5 …”

Section: Introductionmentioning

confidence: 99%

“…Several methods have been described for the treatment of nasal telangiectasia, like microsclerotherapy, electrosurgery, different types of lasers, needle‐assisted electrocoagulation, and TRASER therapy 1,3‐5 …”

Section: Introductionmentioning

confidence: 99%

“…2 Several methods have been described for the treatment of nasal telangiectasia, like microsclerotherapy, electrosurgery, different types of lasers, needle-assisted electrocoagulation, and TRASER therapy. 1,[3][4][5] Microsclerotherapy is the oldest method that consists in the injection of sclerosing agents in the lumen of the vessels in order to induce thrombosis and then fibrosis. Substances like sodium tetradecyl sulfate, hypertonic saline, polidocanol, and Sclerodex have been largely used to treat telangiectasia; however, they were all associated to a certain risk of allergic reactions or superficial necrosis when inadvertently extravasated, especially in small diameter vessels where intravasal injection is difficult to achieve.…”

Section: Introductionmentioning

confidence: 99%

“…3 The laser devices that have been used the most for nasal telangiectasia are CO2 laser, potassium titanyl phosphate (KTP) laser, long-pulsed neodymium:yttrium-aluminum-garnet Nd:YAG(LPNY) laser, erbium:yttrium-aluminum-garnet laser, and intense pulsed light (IPL). 2,5 CO2 lasers have been largely used in the past years for nasal telangiectasia; however, they were usually ineffective or caused atrophic scarring in cases of large diameter vessels. 6 Also, KTP lasers were effective only on small diameter telangiectasia (<1 mm).…”

Section: Introductionmentioning

confidence: 99%

See 4 more Smart Citations

A new technique for the treatment of nasal telangiectasia using atmospheric plasma (voltaic arc dermabrasion): Postoperative pain assessment by thermal infrared imaging

Scarano

Petrini

Inchingolo

et al. 2020

J of Cosmetic Dermatology

View full text Add to dashboard Cite

Background Nasal telangiectasias are superficial, small vessels in the ala nasi and nasolabial crease with a varying origin. They represent an unaesthetic condition, frustrating patients who frequently request their removal. Microsclerotherapy, electrosurgery, different types of laser therapy, needle‐assisted electrocoagulation, and TRASER therapy have been described for treating this condition. Aims The aim of this study is to describe a novel technique that removes nasal telengectiasias using voltaic arc dermabrasion (VAD). Patients/Methods Voltaic arc dermabrasion treatment was used to remove nasal telangiectasia in 23 patients. The post‐treatment condition was monitored by means of photographic records and the evaluation of erythema, pain score, patient and surgeon satisfaction, and skin temperature. The timing points were 1, 4, 6 days and 1 year after treatment. Results Patients referred a moderate pain during the treatment that ceased at the end of the procedure. Moderate erythema and punctiform fine crusting were present in all patients that lasted until the 6th day after treatment. No other adverse effects were observed. After 1‐year, the mean patient and surgeon satisfaction scores were 2.90 and 3.00 ± 0.3, respectively. A single treatment was effective in 85% of the patients and no recurrences were recorded for one year. The skin temperature increased about 18.2 ± 3.2°C during the treatment but returned to basal values in about 20 seconds in most of the patients. Conclusion Voltaic arc dermabrasion treatment is a viable, easy to use, and inexpensive tool for successful nasal telangiectasia removal, with minimal post‐treatment discomfort.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

A new technique for the treatment of nasal telangiectasia using atmospheric plasma (voltaic arc dermabrasion): Postoperative pain assessment by thermal infrared imaging

Scarano

Petrini

Inchingolo

et al. 2020

J of Cosmetic Dermatology

View full text Add to dashboard Cite

show abstract

Rosacea treatments: Current standards and additional options

Tan

Singh

Song

et al. 2021

Dermatological Reviews

View full text Add to dashboard Cite

Background Rosacea, a chronic facial and ocular inflammatory disease, is readily visible with consequential adverse psychosocial impacts. Progress in epidemiology, pathophysiology, treatments, psychosocial and quality of life impact has led to improved outcomes. Additionally, there has been a transition to updated clinical criteria for diagnosis and classification, the phenotype approach, based on rosacea‐associated features. Objective Our objective was to identify current evidence‐based standards of treatment for rosacea highlighting recently approved interventions and including innovative options. Methods Reviews establishing current standards of care published over the past three years and English language clinical studies of rosacea treatment from 2018‐ March 2021 were included. In addition to pivotal trials, the latter were also selected based on innovation and practicality of the intervention. Results In addition to treatments identified in guidelines and systematic reviews, additional options derive from use in other dermatological conditions ‐ such as botulinum toxin, hydroxychloroquine, photodynamic therapy, radiofrequency with or without microneedling ‐ or from other medical conditions, such as artemether and sumatriptan. Conclusion We provide a template of longitudinal care for rosacea based on features divided into current standards and additional options. The latter may provide the impetus for further research and development to provide options with greater efficacy, longer remissions and/or lower risk of adverse events to improve outcomes in patients with rosacea.

show abstract

A randomized split‐face comparative study of long‐pulsed alexandrite plus low‐fluence Nd:YAG laser versus pulsed‐dye laser in the treatment of rosacea

et al. 2022

View full text Add to dashboard Cite

Objectives To compare the effectiveness of long‐pulsed alexandrite laser (LPAL) with that of pulsed‐dye laser (PDL) for rosacea. Methods This was a single‐blind randomized controlled trial on 27 patients who were clinically diagnosed with rosacea. Randomly assigned split face in each patient received four times monthly treatment of LPAL plus low‐fluence Nd:YAG with the contralateral side serving as the control treated with PDL. At every visit, the erythema index (EI) was measured with skin analysis systems, and two independent dermatologists evaluated digital photographs for five‐point global aesthetic improvement scale (GAIS). Results The EI significantly decreased on both treated sides (LPAL 366.5 ± 101.0 vs. 295.8 ± 90.2, p < 0.001, PDL 369.0 ± 124.3 vs. 302.7 ± 92.1, p < 0.001) 1 month after fourth treatment (visit 5). Also 3 months after the fourth treatment (visit 6), the reduction in the EI was well maintained on both sides (LPAL 360.3 ± 96.8 vs. 282.0 ± 89.2, p < 0.001, PDL 364.3 ± 121.6 vs. 281.6 ± 97.8, p < 0.001). When comparing the improvement in the EI between the two groups, the percentage reduction in the EI on the LPAL‐treated side was not inferior to the PDL‐treated side (visit 5: LPAL 18.7 ± 15.7% vs. PDL 16.4 ± 12.9%, p = 0.501 and visit 6: LPAL 21.7 ± 13.9% vs. PDL 21.9 ± 15.2%, p = 0.943). The GAIS and patient satisfaction were comparable between the LPAL and PDL sides and did not show any significant difference. No serious adverse events occurred on either of the treated sides. Conclusion This study showed that the decrease in EI in the treatment of rosacea was comparable between PDL and LPAL. Therefore, LPAL could be a promising alternative treatment option with good merits for rosacea, considering no consumables are required for device maintenance.

show abstract

Comparison of efficacy between long-pulsed Nd:YAG laser and pulsed dye laser to treat rosacea-associated nasal telangiectasia

Abstract: Both LPNY and PDL are effective in treating rosacea-associated nasal telangiectasia. If LPNY is used properly to avoid side effects with careful consideration, it can also be used as a good modality.

Cited by 18 publications

References 11 publications

A new technique for the treatment of nasal telangiectasia using atmospheric plasma (voltaic arc dermabrasion): Postoperative pain assessment by thermal infrared imaging

A new technique for the treatment of nasal telangiectasia using atmospheric plasma (voltaic arc dermabrasion): Postoperative pain assessment by thermal infrared imaging

Rosacea treatments: Current standards and additional options

A randomized split‐face comparative study of long‐pulsed alexandrite plus low‐fluence Nd:YAG laser versus pulsed‐dye laser in the treatment of rosacea

Contact Info

Product

Resources

About